Author

L. Alinari

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:metabolomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Hart· 1 shared A. Sircar· 1 shared F. Choueiry· 1 shared J. Zhu· 1 shared L. Sehgal· 1 shared N. Epperla· 1 shared R. Baiocchi· 1 shared S. Singh· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Hart

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Multiomics Integration Elucidates Metabolic Modulators of Drug Resistance in Lymphoma

F. Choueiry, S. Singh, X. Sun, S. Zhang, A. Sircar, A. Hart, L. Alinari, N. Epperla, R. Baiocchi, J. Zhu, L. Sehgal

This study identifies metabolic reprogramming in ibrutinib-resistant DLBCL using multi-omics integration, revealing the BTK-PI3K-AKT-IL4I1 axis as a key driver of drug resistance.

bioRxiv · Jan 7, 2021 · PreprintCancer Biology